| Literature DB >> 32118110 |
Takaaki Kishino1, Kazuyuki Kanemasa1, Yoko Kitamura1, Kohei Fukumoto1, Naoki Okamoto1, Hideto Shimokobe1.
Abstract
Background and study aims The efficacy of endoclips for colonic diverticular hemorrhage remains unclear. The aim of the current study was to evaluate the safety and efficacy of endoclips versus endoscopic band ligation (EBL) for the treatment of colonic diverticular hemorrhage. Patients and methods At Nara City Hospital, 93 patients with colonic diverticular hemorrhage with stigmata of recent hemorrhage (SRH) were treated using endoclips or EBL between January 2013 and December 2018. We classified the patients treated by endoclips into the direct clipping group and indirect clipping group. Endoclips were placed directly onto the vessel if technically feasible (direct clipping). When direct placement of endoclips onto the vessel was not possible, the diverticulum was closed in a zipper fashion (indirect clipping). Patient demographics, rate of early rebleeding within 30 days after initial treatment, and complications were retrospectively evaluated. Results Of the 93 patients, 34, 28, and 31 were in the direct clipping group, indirect clipping group, and EBL group, respectively. Rates of early rebleeding in the direct clipping, indirect clipping, and EBL groups were 5.9 % (2/34), 35.7 % (10/28), and 6.5 % (2/31), respectively ( P = 0.006: direct clipping vs indirect clipping, P = 1: direct clipping vs EBL). No complications occurred in any groups. All patients who had early rebleeding in the direct clipping group underwent EBL, and no further bleeding occurred after repeat therapy. Conclusions Direct clip placement is acceptable as the first treatment choice for colonic diverticular hemorrhage. When direct placement of endoclips is not possible, EBL should be performed instead of indirect clipping.Entities:
Year: 2020 PMID: 32118110 PMCID: PMC7035034 DOI: 10.1055/a-1036-6077
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Endoscopic hemostasis with endoclips. a1 Colonic diverticulum with a non-bleeding visible vessel. a2 Endoclips were placed directly onto the vessel (direct clipping). b1 Active bleeding from the colonic diverticulum. b2 The diverticulum was closed in a zipper manner (indirect clipping).
Fig. 2Types of endoclips. a HX-610-090S (short clip). b HX-610-135 (middle clip). c HX-610-090 L (long clip); EZ CLIP, Olympus Optical Company Ltd.
Characteristics of patients who underwent endoscopic hemostasis for colonic diverticular hemorrhage with SRH
| Direct clipping (n = 34) | Indirect clipping (n = 28) | EBL (n = 31) |
| |
| Age, years, median (IQR) | 75.5 (68–82.8) | 76 (65.8–82) | 72 (67–86.5) |
0.757
|
| Sex, male, n (%) | 21 (61.8) | 15 (53.6) | 15 (48.4) |
0.567
|
| Comorbidity, n (%) | ||||
Hypertension | 20 (58.8) | 14 (50.0) | 20 (64.5) |
0.541
|
Hyperlipidemia | 5 (14.7) | 1 (3.6) | 4 (12.9) |
0.342
|
Diabetes mellitus | 3 (8.8) | 3 (10.7) | 11 (39.3) |
0.014
|
Chronic kidney disease | 4 (11.8) | 2 (7.1) | 1 (3.2) |
0.491
|
Heart disease | 3 (8.8) | 5 (17.9) | 8 (25.8) |
0.19
|
Cerebrovascular disease | 2 (5.9) | 4 (14.3) | 9 (29.0) |
0.045
|
| Usage of antithrombotic agents, n (%) | 10 (29.4) | 7 (25.0) | 17 (54.8) |
0.039
|
Single agent | 9 | 5 | 15 | |
Combination use | 1 | 2 | 2 | |
| Usage of NSAIDs, n (%) | 8 (23.5) | 8 (28.6) | 14 (45.2) |
0.185
|
| Usage of steroids, n (%) | 1 (2.9) | 1 (3.6) | 0 (0) |
0.754
|
| Previous history of colonic diverticular hemorrhage, n (%) | 19 (55.9) | 10 (35.7) | 18 (58.1) |
0.178
|
| Hb on admission, g/dL, median (IQR) | 11 (9.2–12.8) | 11.8 (9.1–12.6) | 12.1 (10.2–13.7) |
0.1
|
| Shock index on admission, median (IQR) | 0.64 (0.51–0.75) | 0.63 (0.57–0.78) | 0.64 (0.54–0.82) |
0.952
|
SRH, stigmata of recent hemorrhage; IQR, interquartile range; NSAIDs, nonsteroidal anti-inflammatory drugs; Hb, hemoglobin; EBL, endoscopic band ligation
One-way analysis of variance
Fisher’s exact test
Clinical outcomes of patients who underwent endoscopic hemostasis for colonic diverticular hemorrhage with SRH.
| Direct clipping (n = 34) | Indirect clipping (n = 28) | EBL (n = 31) |
| |
| SRH (AB/ NBVV or AC), n | 13/21 | 22/6 | 21/10 |
0.004
|
| Location (proximal: C, A, T/ distal: D, S), n | 29/5 | 19/9 | 21/10 |
0.181
|
| Bleeding point in the diverticulum (dome/neck/unconfirmed), n | 30/3/1 | 6/0/22 | 14/2/15 | |
|
Total procedure time
| 34 (26.3–52) | 31.5 (20.8–55.3) | 51 (38–72.5) |
0.012
|
| Time to hemostasis after identification of the bleeding site, min, median (IQR) | 9 (5.5–13) | 6 (3.8–11.3) | 24 (14–31.5) |
< 0.001
|
|
Early rebleeding
| 2 (5.9) | 10 (35.7) | 2 (6.5) |
0.003
|
| Time to discharge after initial hemostasis, day, median (IQR) | 7 (5–8) | 6.5 (6–9) | 5 (4–7) |
0.1
|
| Units of PRBCs, median (IQR) | 0 (0–2) | 0 (0–4) | 0 (0–0) |
0.195
|
| Complications, n | 0 | 0 | 0 |
1
|
SRH, stigmata of recent hemorrhage; AB, active bleeding; NBVV, non-bleeding visible vessel; AC, adherent clot; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon; IQR, interquartile range; PRBCs, packed red blood cells; EBL, endoscopic band ligation.
Fisher’s exact test
The total procedure time is defined as the total time from the start to end of colonoscopy
One-way analysis of variance
Early rebleeding is defined as rebleeding within 30 days of initial hemostasis
Welch’s test
Fig. 3Flowchart of treatment results. SRH, stigmata of recent hemorrhage; EBL, endoscopic band ligation; TAE, transcatheter arterial embolization; Early rebleeding, recurrent bleeding within 30 days of treatment. * P = 0.006 for the direct clipping group vs the indirect clipping group; ** P = 1 for the direct clipping group vs the EBL group. P values were calculated with Bonferroni corrections.
Annual changes in endoscopic hemostasis and rebleeding.
| Endoscopic hemostasis | ||||||
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| Direct clipping, n | 0 | 3 | 5 | 11 | 5 | 10 |
| Indirect clipping, n | 5 | 9 | 7 | 4 | 2 | 1 |
| EBL, n | 0 | 0 | 0 | 5 | 10 | 16 |
| Rebleeding cases according to endoscopic hemostasis | ||||||
| Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| Direct clipping, n | 0 | 0 | 0 | 0 | 1 | 1 |
| Indirect clipping, n | 2 | 2 | 3 | 2 | 0 | 1 |
| EBL, n | 0 | 0 | 0 | 0 | 2 | 0 |
EBL, endoscopic band ligation.
Characteristics of recurrent bleeding and non-recurrent bleeding groups after endoscopic hemostasis.
| Non-recurrent bleeding (n = 79) | Recurrent bleeding (n = 14) |
| |
| Age, years, median (IQR) | 75 (66.5–82.5) | 78 (69.3–85.3) | 0.572 |
| Sex, male, n (%) | 45 (57.0) | 6 (42.9) | 0.39 |
| Comorbidity, n (%) | |||
Hypertension | 48 (60.8) | 6 (42.9) | 0.248 |
Hyperlipidemia | 9 (11.4) | 1 (7.1) | 1 |
Diabetes mellitus | 17 (21.5) | 0 (0) | 0.065 |
Chronic kidney disease | 7 (8.9) | 0 (0) | 0.589 |
Heart disease | 15 (19.0) | 1 (7.1) | 0.45 |
Cerebrovascular disease | 12 (15.2) | 3 (21.4) | 0.693 |
| Usage of antithrombotic agents, n (%) | 28 (35.4) | 6 (42.9) | 0.764 |
| Usage of NSAIDs, n (%) | 25 (31.6) | 5 (35.7) | 0.764 |
| Usage of steroids, n (%) | 2 (2.5) | 0 (0) | 1 |
| Previous history of colonic diverticular hemorrhage, n (%) | 40 (50.6) | 7 (50.0) | 1 |
| Endoscopic hemostasis, n (%) | 0.003 | ||
Direct clipping | 32 (40.5) | 2 (14.3) | |
Indirect clipping | 18 (22.8) | 10 (71.4) | |
EBL | 29 (36.7) | 2 (14.3) | |
| SRH (AB/ NBVV or AC), n | 44/35 | 12/2 | 0.041 |
| Location (proximal: C, A, T/ distal: D, S), n | 60/19 | 9/5 | 0.343 |
| Bleeding point in the diverticulum (dome/neck/unconfirmed), n | 44/5/30 | 6/0/9 | 0.417 |
|
Total procedure time
| 40 (29–57) | 28 (17.3–63) | 0.429 |
| Time to hemostasis after identification of the bleeding site, min, median (IQR) | 12 (7–19) | 9.5 (3.5–13) | 0.247 |
IQR, interquartile range; NSAIDs, nonsteroidal anti-inflammatory drugs; EBL, endoscopic band ligation; SRH, stigmata of recent hemorrhage; AB, active bleeding; NBVV, non-bleeding visible vessel; AC, adherent clot; C, cecum; A, ascending colon; T, transverse colon; D, descending colon; S, sigmoid colon.
The total procedure time is defined as the total time from the start to end of colonoscopy
Multilevel logistic regression analysis to identify independent risk factors associated with early rebleeding.
| Odds ratio | 95 % CI |
| |
| Age | 0.998 | 0.93–1.07 | 0.948 |
| Sex (Male) | 0.457 | 0.11–1.96 | 0.291 |
| Usage of antithrombotic agents | 2.67 | 0.587–12.2 | 0.204 |
| Usage of NSAIDs | 1.22 | 0.287–5.18 | 0.789 |
| SRH (active bleeding) | 3.83 | 0.644–22.8 | 0.14 |
| Endoscopic hemostasis | |||
| EBL | 1 | ||
| Direct clipping | 1.91 | 0.216–16.8 | 0.561 |
| Indirect clipping | 12.7 | 2.02–79.4 | 0.0067 |
NSAIDs, nonsteroidal anti-inflammatory drugs; SRH, stigmata of recent hemorrhage; EBL, endoscopic band ligation; CI, confidence interval.
Fig. 4 aAn open endoclip (HX-610-090S; EZ CLIP, Olympus Optical Company Ltd.). b After the open endoclip is placed into the forceps hole of the endoscope, the width of the endoclip becomes narrower.
Fig. 5 aActive bleeding from the colonic diverticulum. b Bleeding was stopped after direct clip placement. c An exposed vessel with a clot beside the endoclips (yellow arrow). d The diverticulum was pulled via suction into the cup of the endoscopic ligator, and the elastic O-ring was released. The yellow arrow indicates the diverticulum with endoclips after EBL.